Dietary guidelines and health—is nutrition science up to the task?
暂无分享,去创建一个
[1] N. Board.. Redesigning the Process for Establishing the Dietary Guidelines for Americans , 2017 .
[2] N. Board.. Optimizing the Process for Establishing the Dietary Guidelines for Americans: The Selection Process , 2017 .
[3] L. Bero. Developing reliable dietary guidelines , 2017, British Medical Journal.
[4] T. Frieden. Evidence for Health Decision Making — Beyond Randomized, Controlled Trials: The Changing Face of Clinical Trials , 2017, The New England journal of medicine.
[5] D. Mozaffarian. Conflict of Interest and the Role of the Food Industry in Nutrition Research. , 2017, JAMA.
[6] D. Mozaffarian,et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States , 2017, JAMA.
[7] Jessica Tran,et al. Do Sugar-Sweetened Beverages Cause Obesity and Diabetes? Industry and the Manufacture of Scientific Controversy , 2016, Annals of Internal Medicine.
[8] L. Bero,et al. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. , 2016, JAMA internal medicine.
[9] L. Bero,et al. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews , 2016, PloS one.
[10] D. Mozaffarian,et al. Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials , 2016, PLoS medicine.
[11] D. van der A,et al. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study , 2016, PLoS medicine.
[12] D. Mozaffarian,et al. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. , 2016, JAMA internal medicine.
[13] D. Yach,et al. Should we welcome food industry funding of public health research? , 2016, British Medical Journal.
[14] S. Nissen. U.S. Dietary Guidelines: An Evidence-Free Zone , 2016, Annals of Internal Medicine.
[15] D. Mozaffarian. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.
[16] Xinyan Jiang,et al. Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials , 2015, Menopause.
[17] V. Montori,et al. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. , 2015, The Journal of clinical endocrinology and metabolism.
[18] M. Nestle. Soda Politics: Taking on Big Soda (and Winning) , 2015 .
[19] D. Mozaffarian,et al. The 2015 US Dietary Guidelines: Lifting the Ban on Total Dietary Fat. , 2015, JAMA.
[20] Andrew A. Toole,et al. Federal Support for Nutrition Research Trends Upward as USDA Share Declines , 2015 .
[21] Anne Eisinga,et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. , 2015, The Cochrane database of systematic reviews.
[22] J. Merino,et al. Exclusion of ‘nonRCT evidence’ in guidelines for chronic diseases – is it always appropriate? The Look AHEAD study , 2014, Current medical research and opinion.
[23] L. Bero,et al. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. , 2014, The Cochrane database of systematic reviews.
[24] M. Schulze,et al. Financial Conflicts of Interest and Reporting Bias Regarding the Association between Sugar-Sweetened Beverages and Weight Gain: A Systematic Review of Systematic Reviews , 2013, PLoS medicine.
[25] J. Ioannidis. Implausible results in human nutrition research , 2013, BMJ.
[26] D. Mozaffarian,et al. Mediterranean diet for primary prevention of cardiovascular disease. , 2013, The New England journal of medicine.
[27] Sergio Sismondo,et al. Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.
[28] D. Mozaffarian,et al. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.
[29] D. Mozaffarian,et al. Components of a Cardioprotective Diet: New Insights , 2011, Circulation.
[30] Douglas P. Zipes,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .
[31] P. Libby,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .
[32] D. Mozaffarian,et al. Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.
[33] B. Fielding,et al. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.
[34] R. Mensink,et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.
[35] Heidi D Nelson,et al. Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.
[36] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[37] D R Jacobs,et al. Reductionism and the narrowing nutrition perspective: time for reevaluation and emphasis on food synergy. , 2001, Journal of the American Dietetic Association.
[38] J. Concato,et al. Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.
[39] N. Wintfeld,et al. Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.
[40] G. Colditz,et al. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. , 1993, American journal of obstetrics and gynecology.
[41] M. Singer,et al. Nutritional Epidemiology , 2020, Definitions.